Task: Answer the multiple-choice question.
Question: Which compound exhibits a -39.402% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) N#Cc1c2n(c3c(=O)n(Cc4ccccc4)cnc13)CCCC2
(b) CCOC(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCCC1
Answer: a. N#Cc1c2n(c3c(=O)n(Cc4ccccc4)cnc13)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c2n(c3c(=O)n(Cc4ccccc4)cnc13)CCCC2
N#Cc1c2n(c3c(=O)n(Cc4ccccc4)cnc13)CCCC2
3-benzyl-4-oxo-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile